INOVAIT Launches Winter 2026 Pilot Fund Call for Applications to Advance AI and Image-Guided Therapy Innovations INOVAIT, Canada’s leading network for image-guided therapy (IGT) and artificial intelligence (AI), has opened a new call for applications for its Winter 2026 Pilot…
Cleveland Diagnostics Appoints Michael Iskra as CEO to Accelerate Growth Following FDA Approval of IsoPSA® Assay Cleveland Diagnostics, a pioneering commercial-stage precision oncology company, has announced the appointment of Michael Iskra as its new Chief Executive Officer. With more than…
Donor Alliance Marks Record-Breaking 2025, Saving More Lives Than Ever in Colorado and Wyoming Despite a period of major change in the national organ donation and transplantation landscape, Donor Alliance has achieved historic results in 2025, reaching new heights in…
LuskinOIC Establishes New Research Award to Honor Legacy of Dr. Harry A. McKellop The Luskin Orthopaedic Institute for Children (LuskinOIC) has announced the creation of a new research award designed to recognize and celebrate exceptional achievement and innovation in orthopaedic…
Dental Intelligence Appoints Scott Johnson as CEO to Lead Next Phase of Growth and Innovation Dental Intelligence, a leading provider of practice performance solutions for the dental industry, today announced that its Board of Directors has appointed Scott Johnson as…
Life Sciences Ontario Announces 2026 Awards Celebrating Excellence, Leadership, and Innovation Across the Life Sciences Sector Life Sciences Ontario (LSO) has announced the recipients of the 2026 LSO Awards, recognizing outstanding leadership, innovation, and service across Ontario’s dynamic life sciences…
QIAGEN Appoints Mark Stevenson to Supervisory Board, Strengthening Governance and Operational Expertise QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA), a global leader in sample and assay technologies serving molecular diagnostics, life sciences research, and applied testing markets, has announced the…
CorriXR Therapeutics Publishes Peer-Reviewed Preclinical Study Demonstrating CRISPR-Based NRF2 Editing Restores Chemosensitivity in Treatment-Resistant Solid Tumors CorriXR Therapeutics, an oncology-focused biotherapeutics company developing next-generation genetic medicines to overcome drug resistance in solid tumors, has announced the publication of new peer-reviewed…
Leveraging AI and Cloud Solutions to Enhance Patient Care and Operational Efficiency SAP and Fresenius today announced that both companies intend to enter a strategic partnership to accelerate innovation for stronger digital healthcare delivery. Together, the companies plan to create…
Strengthening supply chains and partnerships to deliver timely flu vaccines nationwide Vaccine distribution places higher demands on logistics than many other types of pharmaceuticals. Volumes rise sharply during the flu season, delivery windows are narrow and temperature control must hold…